BamSEC and AlphaSense Join Forces
Learn More

Jade Biosciences Inc. – Indentures

NASDAQ: JBIO    
Share price (11/6/26): $15.07    
Market cap (11/6/26): $958 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.5
from S-3 52 pages Jade Biosciences, Inc. Indenture Dated as of , 20___ [ ] Trustee
12/34/56
EX-4.4
from 10-K 8 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended Description of Capital Stock
12/34/56
EX-4.4
from 424B3 8 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended Description of Capital Stock
12/34/56
EX-4.4
from 424B3 8 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended Description of Capital Stock
12/34/56
EX-4.3
from 424B3 13 pages Jade Biosciences, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.3
from 424B3 13 pages Jade Biosciences, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.3
from 10-K 13 pages Jade Biosciences, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 17 pages Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 14 pages Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.4
from S-4/A 14 pages Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.4
from S-3 39 pages Aerovate Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [·], 202[·] Subordinated Debt Securities
12/34/56
EX-4.3
from S-3 39 pages Aerovate Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [·], 202[·] Senior Debt Securities
12/34/56
EX-4.4
from S-3 39 pages Aerovate Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [●], 202[●] Subordinated Debt Securities
12/34/56
EX-4.3
from S-3 39 pages Aerovate Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [●], 202[●] Senior Debt Securities
12/34/56
EX-4.3
from 10-K 5 pages Description of Securities
12/34/56
EX-4.1
from S-1/A 2 pages Indenture or similar
12/34/56
EX-4.2
from S-1 34 pages Investors’ Rights Agreement
12/34/56
EX-4.2
from DRS 34 pages Investors’ Rights Agreement
12/34/56